NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

Active Not RecruitingN/A

Sponsor: AstraZeneca

Conditions: Pulmonary Disease, Chronic Obstructive

Interventions: Budesonide/glycopyrrolate/formoterol fumarate

Countries: Canada, Germany, Greece, Italy, Japan, Romania, United Kingdom

The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with moderate to severe COPD and initiating BGF treatment according to the local prescribing guidance and as per their treating physician's recommendation
* Enrolled in on-going single-arm studies
* Provided consent for secondary use of data

Exclusion Criteria:

* Did not provide consent for secondary use of data

Locations (7)

Mississauga, Canada
Hamburg, Germany
Athens, Greece
Milan, Italy
Tokyo, Japan
Bucharest, Romania
London, United Kingdom